Replimune Group, Inc. (REPL) stock
REPLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q/A on Nov 6, 2026Score 1/30
$19.69−1.72 (-8.03%)
Close on Nov 17, 2026Market cap $1.87BP/E –Yield –
Replimune market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Replimune's market cap was $1.83B on Nov 11, 2026, against $784.03M a year earlier. Over the last 5 years it ranged from $204.65M to $1.83B, with a median of $803.33M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.83B | +140.0% |
| 2025 | Dec 31, 2025 | $762.08M | -8.0% |
| 2024 | Dec 31, 2024 | $828.26M | +66.4% |
| 2023 | Dec 29, 2023 | $497.87M | -63.2% |
| 2022 | Dec 30, 2022 | $1.35B | +6.5% |
| 2021 | Dec 31, 2021 | $1.27B | -17.4% |
| 2020 | Dec 31, 2020 | $1.54B | +237.9% |
| 2019 | Dec 31, 2019 | $455.17M | +44.3% |
| 2018 | Dec 31, 2018 | $315.54M | – |
See a number that looks wrong?